icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 22-26 2022
Back grey_arrow_rt.gif
 
 
 
Evaluation of the disposition and mass balance recovery of vebicorvir,
a first-generation hepatitis B core inhibitor, in rats and humans

 
 
  EASL 2022 June 22-26 London
 
Katie Zomorodi, Luisa M. Stamm, William Delaney, Michael Shen Assembly Biosciences, Inc., South San Francisco, CA, USA

0705221

0705222

0705223

0705224

0705225

0705226

0705227

0705228

0705229